Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping technology, in partnership with Hitachi High-Tech ...

Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies for cancer and other serious diseases, presented detailed data on its lentiviral vector retargeting ...

With the global shift toward novel biologics, next-generation biosimilars, and human-relevant, non-animal testing models, Biologics X 3DCC 2026 calls upon scientists, innovators, and leaders to help ...

Detailed price information for Solid Biosciences Inc (SLDB-Q) from The Globe and Mail including charting and trades.

Discover eight signs of arthritis in dogs and gentle tips to keep your pet comfortable, supported and happy through the ...

Baystreet.ca News Commentary – The longevity economy is entering a massive repricing event as researchers confirm that ...

In a world of 8 billion people, there's one thing that makes each of us unique: our fingerprints. A variety of genetic and environmental factors ...

Before heading back into the wasteland for “Fallout” season 2, here’s a quick look at the essential moments, locations, and ...

MEDSIR, a leading international company in oncology research, has announced the results of the PHERGuide study during the 2025 San Antonio Breast Cancer Symposium (SABCS). This research, presented as ...

AMCP Nexus 2025 explored innovative health care policies, oncology advancements, and the impact of new regulations on patient ...

Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA. Key presentations at the conference highlighted ...

Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention. SAN DIEGO and MENLO ...